During early mammalian development, the genome undergoes profound transitions in chromatin states, topological organization and recruitment of cis regulatory factors involved in transcriptional control. How these three layers of gene regulation interact is the matter of intense research. The Zdbf2 gene-which is involved in growth control-provides a valuable model to study this question: upon exit from naïve pluripotency and prior to tissue differentiation, it undergoes a switch in usage from a distal to a proximal promoter, along with a switch in chromatin states, from polycomb to DNA methylation occupancy. Using an embryonic stem cell (ESC) culture system to mimic this period, we show here that four enhancers contribute to the Zdbf2 promoter switch, concomitantly with dynamic changes in chromosome architecture. Indeed, CTCF plays a key role in partitioning the locus in ESCs, to facilitate enhancer contact with the distal Zdbf2 promoter only. Partition relieving enhances proximal Zdbf2 promoter activity, as observed during differentiation or with mutants that lack local CTCF-based partition. Importantly, we show that CTCF-based regulation occurs independently of the polycomb and DNA methylation pathways. Our study reveals the importance of multi-layered regulatory frameworks to ensure proper spatio-temporal activation of developmentally important genes.
INTRODUCTION
During the early stages of mammalian development, as the embryo implants into uterine wall, the pluripotent cells that will go on to form somatic tissues transition from "naïve" to "primed" for lineage specification (1) . One hallmark of the naïve pluripotent state is globally low DNA methylation, whereas primed cells are highly DNA methylated (2) . Incidentally, chromatin architecture and the underlying histone modification landscape are also dramatically remodeled during this period (3, 4) . Collectively, this process is referred to as epigenetic reprogramming, and it accompanies dynamic changes to the transcriptional landscape.
How DNA methylation, chromatin regulators, and chromosome conformation all cross-talk during epigenetic reprogramming has not fully crystallized. For example, the polycomb-group (PcG) proteins are developmentally important regulators of transcriptional repression; DNA methylation and PcG proteins are typically mutually exclusive at CpG-rich regions of the genome, such as CpG Island (CGI) promoters (5) (6) (7) (8) . Moreover, polycomb complexes have been proposed to be nodes of long-distance genomic interactions (9) (10) (11) . Therefore, it is conceivable that DNA methylation may impact chromatin architecture by influencing the polycomb landscape.
Mammalian genomes are physically subdivided into "regulatory neighborhoods" known as topologically associated domains (TADs), which average roughly one megabase in size (12, 13) . The CCCTC-BINDING FACTOR (CTCF) is absolutely required for TAD formation, and is bound at the majority of TAD borders, restricting inter-TAD interactions (14) . Incidentally, CTCF is DNA methylation sensitive at a large subset of binding sites (15) . It has even been reported in certain cancers, that ectopic DNA methylation impacts CTCF-mediated insulation between topologically associated domains (TADs) (16) .
However, recently studies have suggested that DNA methylation does not play a major role in TAD organization. Firstly, embryonic stem cells which harbor knockouts for three DNA methyltransferases (Dnmt tKO), and are completely devoid of DNA methylation (17) , have a virtually identical TAD landscape as their wild-type (WT) counterparts (18) . Secondly, the somatic TAD organization is mostly established prior to the blastocyst stage, before the de novo DNA methylation program (19) . Therefore, if DNA methylation does play a role in chromatin interactions, it is only at the sub-megabase level. One classic example where this is case is at the imprinted H19/Igf2 locus, where differential methylation of a CTCF-binding site impacts enhancer-promoter looping (20) .
To assess if and how the differentiation program may influence dynamic chromosome architecture, we utilized the imprinted Zdbf2 locus as a model, which provides an intriguing example of dynamic regulation during differentiation. In the naïve state on the paternal allele, the distal Long isoform of Zdbf2 promoter (pLiz) is active. As cells exit naïve pluripotency, a promoter switch occurs, resulting in activation of the proximal Zdbf2 promoter (pZdbf2), located 73 kilobases (kb) downstream. From the primed state and then throughout life, pZdbf2 is the functional promoter while pLiz is constitutively silenced. It should be noted that despite the genomic distance, there is no change in the message between the Liz and Zdbf2 isoforms, thus the promoter switch does not result in protein diversity. Rather, there is a stratified relationship between the two promoters: pLiz activity is absolutely required for deposition of DNA methylation at a somatic differentially methylated region (sDMR). The sDMR DNA methylation, in turn, antagonizes polycombmediated repression, freeing pZdbf2 ( Figure S1A ) (21, 22) . Mice that are deficient for Liz are never able to activate Zdbf2, and this leads to a substantial growth defect. Thus, the Zdbf2 locus provides a valuable model to dissect how promoter switching occurs in concert with shifting chromatin dynamics during cellular differentiation.
We show here using a cell-based approach, that several enhancers cooperate to regulate the dynamics of Liz and/or Zdbf2 promoter activity. Moreover, CTCF-CTCF contacts at the locus change dynamically during differentiation, and contributed to the proper activity of pLiz and pZdbf2. Saliently, CTCF appears to exert its effect epistatically with respect to the DNA methylation and PcG pathways. This implies that there are two largely independent layers of chromatin-based control of Zdbf2: one at the level of chromatin marks and the other at the level of chromatin architecture. The highly regulated nature of Zdbf2 underscores the importance of structural chromosome topology occurring in concert with chromatin marks to control proper spatio-temporal expression of developmentally consequential genes.
RESULTS

Two Classes of Putative Enhancers Lie in the Liz/Zdbf2 Locus
To discover functional genetic elements that regulate Zdbf2 alternative promoter usage during the de novo DNA methylation program, we performed an assay for transposase-accessible chromatin followed by sequencing (ATAC-Seq) (23) in naïve ESCs (cultured in 2i/LIF+vitC), when pLiz is active and pZdbf2 is repressed (22) (Figure 1A ). We previously showed that by differentiating ESCs into primed, highly DNA methylated epiblast-like cells (EpiLCs), we can faithfully recapitulate in vivo pLiz to pZdbf2 promoter usage dynamics (22) . Therefore, we also performed ATAC-Seq in day 7 (D7) EpiLCs ( Figure  1A ). As expected, the ATAC-Seq peak for pLiz diminished as it became repressed and DNA methylated in EpiLCs. An ATAC-Seq peak was already present at pZdbf2 in ESCs; this is correlated with our previous data indicating that pZdbf2 is bivalent and poised in ESCs (22, 24) .
In between the two promoters, four significant peaks were present in both ESCs and EpiLCs, three proximal to pLiz (E1-3), and one adjacent to a CGI that is an apparent border to the H3K27me3 block in ESCs (E4) ( Figure 1A ). Given that these regions of accessible chromatin were not lying on obvious active promoters, we reasoned that they were potential enhancer elements and named them E1 to E4, from the closest to the most distal to pLiz. Therefore we assayed for enrichment of H3K27 acetylation (H3K27ac), a mark of active enhancer elements (25) . E1-3 appeared enriched for the H3K27ac mark in both cell types, while E4 was depleted for H3K27ac in ESCs and then became enriched for the mark in EpiLCs ( Figure 1B ). While E1-3 can be classified as active in ESCs and EpiLCs, the chromatin accessibility and H3K27ac dynamics at E4 are reminiscent of so-called "poised" enhancers ( Figure  S1B ) (26, 27) . Moreover, publicly available data indicates that E4 is marked by P300 in ESCs and shows high levels of vertebrate conservation ( Figure  S1C ), two more features of poised enhancers (26) . . In ESCs there is ~25kb block of H3K27me3 that extends through the Zdbf2 promoter. The H3K27me3 signal depletes after DNA methylation is established. ATAC-seq reveals four prominent peaks of accessible chromatin between the Liz and Zdbf2 promoters. The ATAC-seq peak at the Liz promoter decreases in EpiLCs concomitantly with decreased expression. WGBS: Whole genome bisulfite sequencing. H3K27me3 ChIP-seq data is from Greenberg et al., 2017. All other genomics data was generated for this study. One representative bioreplicate is displayed for each RNA-seq track. See also Figure S1 . (B) H3K27ac ChIP-qPCR at the four inter-promoter ATAC-seq peaks. E1-3 are enriched for the mark in ESCs and EpiLCs, while E4 only becomes enriched in EpiLCs. Data is shown as ± s.e.m. from three biological replicates. See also Figure S1 . (C) 4C-seq tracks from the pZdbf2 VP in ESCs and EpiLCs. Ratios between 4C-seq signals is indicated in between the samples, and gene tracks are below. In EpiLCs, pZdbf2 exhibits increased interactions at the four putative enhancers. The screen shot represents data from one biological replicate (two total). See also Figure S2 .
Statistical analyses were performed by two-tailed unpaired t-test: n.s = not significant, ** P ≤ 0.01, *** P ≤ 0.001.
The general regulator of pluripotency POU5F1/OCT4 is enriched at all of the putative enhancers in both naïve ESCs and EpiLCs (two pluripotent cell types), indicating that both classes of enhancers are likely regulated in a pluripotency-dependent manner (27) . Importantly, publicly available in vivo data from the naïve pluripotent inner cell mass (ICM) of the blastocyst exhibit a chromatin accessibility and H3K27me3 pattern akin to what we observed in ESCs for the Zdbf2 locus, suggesting that the in vivo and in cellula regulation are coherent ( Figure S1C ) (28, 29) .
High Resolution 4C Reveals Enhancer-Promoter Dynamic Interactions
Given that E1-4 exhibit the chromatin signature of enhancer elements, it is possible that the Liz and Zdbf2 promoters undergo dynamic interactions with these regulatory elements during EpiLC differentiation. In order to test this, we performed high-resolution circular chromosome conformation capture followed by sequencing (4C-seq) during differentiation (30, 31) . Available Hi-C data from mouse ESCs indicates that the Zdbf2 locus exists within an "inter-TAD" that spans roughly 650kb ( Figure S2A ) (32) . According to our 4C-seq data, this inter-TAD can be further subdivided, with intraLiz/Zdbf2 locus and intra-Adam23 locus interactions occurring in relatively mutually exclusive domains ( Figure S2B ).
Using the pLiz as a 4C-seq viewpoint (VP), we did not observe distal looping that occurred at high frequency in either ESCs or EpiLCs ( Figure S2C ). However, in ESCs, when Liz is expressed, the promoter did exhibit increased interactions with the E1-3 cluster relative to EpiLCs, all of which are marked by H3K27ac in this cell type ( Figure 1B) . This is consistent with the possibility that E1-3 contribute to Liz regulation. Given the close proximity between pLiz and E1-3, it is not surprising that interactions remained high between them in EpiLCs, when Liz is repressed. No marked looping appeared to occur between pLiz and E4 in either ESCs or EpiLCs.
A clear picture emerged from the 4C-seq analysis for the Zdbf2 promoter (pZdbf2) ( Figure 1C ). In EpiLCs, E1-4 were all marked by H3K27ac, and pZdbf2 is active. Our 4C-seq revealed that in EpiLCs, pZdbf2 exhibits increased contacts with all four of the putative enhancers, indicating a potential cooperative role for E1-4 in Zdbf2 activation.
Determination of Enhancer Function and Regulation
From our 4C-seq analyses we reasoned that E1-3 potentially regulate pLiz in ESCs, while E4 is silent (Figure 2A) . To test this, we generated homozygous deletions of combinations of putative enhancer elements ( Figure S2D ). The E3 element also serves as the promoter of the Gpr1 gene, which is lowly expressed in our system and we previously showed plays no role in Zdbf2 regulation (22) . As such, deleting the element had no impact on expression or DNA methylation at the Zdbf2 locus ( Figure S2E and S2F). If E3 is an enhancer element, it may be redundant with E1 and/or E2. Therefore, we generated a ~13kb deletion that encompassed E1-3 ( Figure 2B and S2C). In the absence of these elements, the Liz transcript was markedly repressed, and the canonical Zdbf2 isoform failed to properly activate ( Figure 2C ). As Liz is required to activate Zdbf2, it should be noted that this deletion does not confirm E1-3 elements regulate pZdbf2. However, the data provide a strong indication that E1-3 are indeed enhancers of pLiz.
We previously showed that DNA methylation accumulates at pLiz after transcription ablates (22) . Interestingly, in the absence of E1-3, DNA methylation accumulated faster at pLiz, perhaps indicating less protection from de novo DNA methyltransferases due to reduced transcription factor occupancy ( Figure 2D ). Liz expression is required for DNA methylation establishment at the sDMR region in cellula and in vivo (22) . It should be noted that in the cell-based system the imprint is lost and both alleles become methylated, but we maintain here the sDMR terminology. In the absence of E1-3, the DNA methylation failed to properly accumulate at the sDMR region, reaching 67% by D7 ( Figure 2D ). This was likely as a consequence of reduced Liz expression, as deletion of pLiz resulted in 45% sDMR methylation (22) .
Upon the promoter switch, E4 became enriched for H3K27ac. We hypothesized that a deletion for E4 would have minimal impact on pLiz, but may affect pZdbf2 activity (Figure 2A and 2E) . Indeed, ∆E4 mutant cells exhibited no alteration of Liz expression, but Zdbf2 transcripts were strongly reduced ( Figure  2F ). As Liz was unaffected, there was no impact on DNA methylation at the locus ( Figure 2G ). Moreover, reduced expression of Zdbf2 in ∆E4 EpiLCs did not correlate with maintained polycomb occupancy in the sDMR region and pZdbf2 ( Figure 2H ). In sum, the ? There is no significant effect on polycomb dynamics in ∆E4 mutation, except mild ectopic spreading upstream of the sDMR region. pPax5 and pOct4 are positive and negative controls, respectively. Data are shown as ± s.e.m. from three biological replicates for each genotype.
Statistical analyses were performed by two-tailed unpaired t-test: n.s = not significant, * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001.
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enhancer E4 is necessary for pZdbf2 activation, regardless of the local DNA methylation or polycomb status.
The E4 enhancer element bears the hallmark of a poised enhancer in that it is enriched for P300 in ESCs, but only becomes active in EpiLCs. However, poised enhancers were originally defined as being enriched for H3K27me3 (26) , whereas E4 is depleted for the mark ( Figure 2H ). H3K27me2, which like H3K27me3 is deposited by polycomb repressive complex 2 (PRC2), has also been reported to prevent firing of enhancers in ESCs (33) . Yet H3K27me2 ChIP analysis revealed that E4 is depleted for this mark as well ( Figure S3A ). E4 does seem to play a role in preventing ectopic polycomb spreading: deleting E4 resulted in a slight increase of H3K27me3 enrichment 1kb upstream of the WT polycomb domain, however the signal was identical to WT levels by 5kb upstream ( Figure 2H ).
We previously showed that in ESCs containing loss-of-function mutations in the Embryonic ectoderm development (Eed) gene (34)-a core component of PRC2-there was precocious activation of pZdbf2 (22) . Therefore, we wanted to observe if a PRC2 mutant would result in a change in the chromatin status of E4. Indeed, both E4 and pZdbf2 became enriched for H3K27ac in the absence of polycomb-mediated repression ( Figure 3A) . Incidentally, pLiz and E1-3, which are already active in ESCs, exhibited no significant change. In ∆Liz mutants, Zdbf2 remains polycomb repressed (22) . As such, in the ∆Liz mutant the E4 enhancer did not attain complete levels of H3K27ac during EpiLC differentiation ( Figure 3B ). In sum, while E4 does not display the signatures of direct polycomb regulation, per se, its activity is controlled in a polycombdependent manner.
Liz Transcription and Polycomb Play a Minor
Role in 3D Organization of the Locus. During differentiation, the transcription initiated from pLiz and traversing the locus is required for polycomb-to-DNA methylation switch, and pZdbf2 activation (22) . However, our 4C-seq analysis revealed that in the absence of Liz transcription, there is only a minor effect on the conformation of pZdbf2 ( Figure S3B ). Moreover, in ∆Liz EpiLCs, pZdbf2 exhibited increased interactions with E1-4, but not to the same extent as WT EpiLCs. It should be noted that the ∆Liz DNA methylation phenotype is only partial in the cell-based system, which may account for the intermediate chromosome conformation phenotype.
The polycomb region that regulates pZdbf2 spans ~25kb, from E4 and into the body of Zdbf2 ( Figure  1A ). Consistent with previous reports, in ESCs this region forms a tightly packed domain (10) ( Figure  1C ). We performed 4C-seq in Eed mutant ESCs in order to determine if polycomb impacts the chromosome conformation ( Figure 3C ). In fact, in a PRC2 mutant, pZdbf2 interacted even more frequently within the polycomb domain. This is likely due to the activation of E4, and increased promoterenhancer looping. It has recently been shown that active promoters exhibit increased agitation in the nucleus, leading to a potential increase of promoterenhancer contacts (35) . Given that pZdbf2 becomes active in Eed mutant ESCs, logic would dictate that it would interact more frequently with E1-3, which are also active. However, our 4C-seq in the polycomb mutant showed that this was not the case ( Figure 3C ). To summarize, Liz transcription and the polycomb status play a limited role in the regulation of the pZdbf2 interaction landscape, and there must be other mechanisms in place.
CTCF Partitions the Liz/Zdbf2 Locus in ESCs
Given that pZdbf2 does not interact with E1-3 in polycomb mutant ESCs, those enhancers must be restricted from forming long-range loops. The most likely candidate to contribute to locus organization is CTCF (36) . We analyzed the 4C-seq patterns of several CTCF binding sites (37) throughout the locus (data available upon request). In ESCs, a CTCFbinding site proximal to the Gpr1 promoter formed a looping structure with two CTCF sites downstream of the Gpr1 gene ( Figure 4A ). Incidentally, pLiz and E1-3 lie within this loop. During differentiation to EpiLCs, this looping structure was reduced. In accordance, the CTCF binding at this site was depleted, whereas CTCF remained bound at the sites downstream of Gpr1 ( Figure 4B ). Therefore, this binding platform will be referred to as the "CTCF_partition site" (CTCF_PS), which physically separates the active pLiz/E1-3 region from the silent pZdbf2/E4 in ESCs ( Figure 4C ). In EpiLCs, depletion of CTCF at the partition site would then allow for pZdbf2 to interact with E1-3, while pLiz is silenced.
Using the CTCF_PS as a VP in our Eed mutant ESCs, we observed that the partition loop still formed ( Figure S3C ). Furthermore, CTCF still remained enriched at the CTCF_PS in PRC2 mutant ESCs 
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( Figure 4B ). The continued formation of the partition in the absence of polycomb-mediated regulation would explain why pZdbf2 failed to exhibit increased interactions with E1-3, even though the promoter has adopted an active state.
Given that CTCF is DNA methylation sensitive at a subset of binding sites (15), we reasoned that perhaps de novo DNA methylation is required for evicting CTCF from the CTCF_PS. We tested this by differentiating Dnmt tKO ESCs, which are able to differentiate to a state akin to WT EpiLCs despite a total lack of DNA methylation (22, 38) . However, even in the absence of DNA methylation, CTCF depleted at the partition site ( Figure S3D) . A recent study reported that transcription can disrupt CTCF binding and chromatin architecture (39), yet we observed reduced CTCF enrichment even in the absence of the Liz transcript ( Figure S3D ). Therefore, the CTCF depletion at the CTCF_PS in EpiLCs is differentiation dependent, but independent of DNA methylation-or Liz transcription-based regulation.
CTCF Partitioning Fine-tunes pLiz Programming of pZdbf2
To assess the regulatory impact of CTCF partitioning, we generated a deletion of the CTCF_PS ( Figure  S4A ). 4C-seq in ∆CTCF_PS ESCs revealed that pLiz interacts less frequently with E1-3 ( Figure S4B ), perhaps as the promoter is less constrained without the CTCF partition. As such, Liz failed to properly express ( Figure 4D ). During differentiation, the Liz transcript was still able to attain WT levels, nevertheless Zdbf2 failed to properly activate ( Figure  4D ). Moreover, while DNA methylation occurred normally at pLiz, the sDMR remained relatively hypomethylated compared to WT ( Figure 4E ), likely due to the delayed kinetics of Liz upregulation. Furthermore, the relative reduction of DNA methylation at the sDMR in ∆CTCF_PS mutant EpiLCs was correlated with a slight retention of H3K27me3 in comparison with WT, which may contribute to the failure of pZdbf2 to properly activate ( Figure 4D and S4C) .
In ∆CTCF_PS mutant ESCs, pZdbf2 exhibited increased contacts with E2 and E3 ( Figure S4B ). However, Zdbf2 remained repressed, as polycomb enrichment remained unperturbed ( Figure S4C ). Given that in PRC2 mutant ESCs, Zdbf2 is already partially de-repressed, we reasoned that by generating an Eed mutation in combination with deleting the partition site, we could observe further increase in Zdbf2 expression, as pZdbf2 would be unhindered from interacting with all four enhancers ( Figure S4D ). In parallel, we generated a new Eed mutation, so all cell lines would be in the identical genetic background ( Figure S4D ). We confirmed that the Eed mutant lines failed to exhibit EED protein nor H3K27me3 by western blotting ( Figure S4E ). Moreover, they showed no signs of precocious differentiation to EpiLCs ( Figure S4F ). Indeed, while Zdbf2 was upregulated in absence of Eed alone, the expression was significantly increased in the ∆CTCF-PS ; Eed-/-double mutant ( Figure 4F ). Therefore, we concluded that in addition to contributing to proper pLiz activation, the CTCF partition acts as a second level of protection, along with polycomb, to restrain precocious pZdbf2 firing.
DISCUSSION
In this study, we revealed the dynamic chromosome conformation of the Liz/Zdbf2 locus that occurs concomitantly with epigenetic programming during differentiation. For proper Zdbf2 activation, it is imperative to properly control Liz expression at the time de novo DNA methylation occurs. Here we show that a CTCF-structured loop organization forms in naïve ESCs. This partition allows for proper regulation of pLiz, which in turn can facilitate the epigenetic switch through Liz transcription. During differentiation the partitioning is relaxed, as pLiz becomes shut down, thus allowing distal enhancers to bolster pZdbf2 activation. Deleting the CTCF_PS resulted in reduced Liz activation kinetics, but a fairly substantial effect on Zdbf2 expression. This is in line with our previously published pLiz transcriptional interruption line, where Liz expression and DNA methylation are only moderately affected, but nonetheless Zdbf2 cannot attain WT levels of activation (22) . Such results underscore the sensitivity of pZdbf2 activity to proper epigenetic programming.
In ∆CTCF_PS ESCs, Zdbf2 transcription did not ectopically occur, even though there were no longer apparent restrictions for pZdbf2 to interact with the active enhancers E1-3. The explanation for this is the polycomb-mediated silencing that persists over pZdbf2 in the absence of CTCF_PS. In fact, the data suggest that the dynamics of the CTCF/partition axis and the polycomb/DNA methylation axis are decoupled at the Zdbf2 locus. Thus, there are at least two layers of regulation of Zdbf2 activation that act independently from classical transcription factor Zdbf2 Expression -ESCs Statistical analyses were performed by two-tailed unpaired t-test: n.s. = not significant, * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001.
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control at gene promoters: 1) instructive chromosome conformation allowing for proper pLiz and pZdfb2 activity, and 2) a Liz-dependent epigenetic switch to evict polycomb at pZdbf2. This hierarchical model emphasizes the exquisite choreography that can occur to program developmentally important genes during the exit from the naïve pluripotent state.
One outstanding question is what is the cue that releases CTCF from the partition site during differentiation? The obvious candidate was DNA methylation, and while CTCF binding at the site may indeed be DNA methylation-sensitive, we found that CTCF was depleted during differentiation, whether the methyl mark was present or not. Another likely explanation is that CTCF is bound in combination with pluripotency-associated transcription factors. While CTCF is generally reported to be largely invariant across mammalian cell types (40) , there are cell type-specific CTCF binding patterns, and roughly 60% occur in a DNA methylation-independent manner (15) . For example, TATA BINDING PROTEIN ASSOCIATED FACTOR 3 (TAF3) is highly expressed in mouse ESCs, and mediates chromosome looping in concert with CTCF to regulate germ layer specification upon differentiation (41) . While TAF3 does deplete in certain ESC differentiation protocols, at the RNA level it remains highly expressed in EpiLCs (RNA-seq from this study), which suggests it is not the factor controlling the partition at the Liz/Zdbf2 locus. However, future experiments will be needed to test this possibility.
Our study presents a rare description of two alternative promoters utilizing a shared set of enhancers, but in a CTCF-guided, developmentally timed manner. In ESCs, CTCF is required to facilitate one promoter's interactions (pLiz) while restricting the other's (pZdbf2). Only upon removal of CTCF binding, the opportunity for pZdbf2 is created to contact its enhancers. On its face, such a mechanism resembles the imprinted Igf2/H19 locus, where CTCF binding near the H19 gene on the maternal allele restrict interactions between a shared set of enhancers and the more distal Igf2 gene (42) . The Igf2/H19 locus behaves differently than the Liz/Zdbf2 locus, though, as differential CTCF binding is DNA methylationdependent and set in the gametes-not dynamically regulated during cellular differentiation. Moreover, Igf2 and H19 are two different genes, not isoforms of the same gene.
CTCF has been shown to mediate enhancer switching. For example, at the Hoxd locus in mice, CTCF facilitates the interactions between the same set of gene promoters but different sets of enhancers depending on the context (43) . Pertinently, dynamic enhancer switching during the naïve-to-primed differentiation is a common mechanism in mammals to maintain gene expression during this cellular transition (44); notably, the key pluripotency regulator Oct4 relies on an ESC-and EpiLC-specific enhancers (45, 46) . However, such an example represents an inverse scenario from Zdbf2, as the Oct4 promoter remains unchanged.
Promoter switching is a widespread and developmentally important phenomenon (47). Aberrant promoter usage is associated with pathologies, such as cancer (48). CTCF is a likely candidate to organize genic three-dimensional structure and protect from aberrant promoter firing, as it does at Zdbf2. The Zdbf2 locus presents a compelling case, because if pLiz-to-pZdbf2 promoter switch does not occur at the proper developmental time, synchronized with the de novo DNA methylation program, pZdbf2 cannot be activated (22) . Notably, the organization of this locus is conserved between mouse and humans, implying the likelihood of a shared regulatory mechanism (21) . Future studies should continue to shed light on the role that CTCF dynamics play in programming developmentally important promoter activity in the crucial window that precedes somatic tissue formation.
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Generation of edited ESCs
All deletions in this study were generated with two CRISPR single guide RNAs (sgRNAs) specific to the target sequences followed by Cas9 nuclease activity and screedning for non-homologous end joining. sgRNAs were designed using the online CRISPOR online program (crispor.tefor.net) and cloned into the pX459 plasmid harboring the Cas9 gene. All sgRNA sequences are listed in Table S1 . Around five million WT serum-grown ESCs were transfected with 1-3µg of plasmid(s) using Amaxa 4d Nucleofector (Lonza) and plated at a low density. Ninety-six individual clones were picked and screened by PCR. Mutated alleles were confirmed by Sanger sequencing of cloned PCR amplicons. In the case of the Eed mutation, loss-offunction was further confirmed by immunoblotting.
DNA methylation analyses
Genomic DNA from cells was isolated using the GenElute Mammalian Genomic DNA Miniprep Kit (Sigma), with RNase treatment.
Bisulfite conversion was performed on 500-1000ng of DNA using the EpiTect® Bisulfite Kit (Qiagen). Bisulfite-treated DNA was PCR amplified and analyzed by pyrosequencing. Pyrosequencing was performed on the PyroMark Q24 (Qiagen) according to the manufacturer's instructions, and results were analyzed with the associated software. All bisulfite primers are listed in Table S1 . Statistical analyses were performed by a two-tailed unpaired t-test using GraphPad Prism6 software.
WGBS data from ESCs were previously generated (10) and EpiLCs were prepared from 50ng of bisulfite-converted genomic DNA using the EpiGnome/Truseq DNA Methylation Kit (Illumina) following the manufacturer instructions. Sequencing was performed in 100pb paired-end reads at a 30X coverage using the Illumina HiSeq2000 platform.
ATAC-seq
ATAC-Seq was performed as described in Buenrostro et al., 2015 with minor modifications. Briefly, 50,000 cells were washed, but not lysed. Cells were transposed using the Nextera DNA library prep kit (Illumina) for 30 min at 37º. DNA was immediately purified using Qiagen MinElute Kit (Qiagen). qPCR was used to determine the optimal cycle number for library amplification. The libraries were sequenced on the Illumina HiSeq2500 platform to obtain 2x100 paired-end reads.
Chromatin immunoprecipitation (ChIP)
ChIP was performed exactly as described in Walter et al., 2016 . Briefly, cells were cross-linked directly in 15cm culture plates with 1% formaldehyde. After quenching with 0.125 M glycine, cells were washed in PBS and pelleted. After a three-step lysis, chromatin was sonicated with a Bioruptor (Diagenode) to reach a fragment size averaging 200 bp. Chromatin corresponding to 10 µg of DNA was incubated rotating overnight at 4°C with 3-5 µg of antibody. A fraction of chromatin extracts (5%) were taken aside for inputs. Antibody-bound chromatin was recovered using Protein G Agarose Columns (Active Motif). The antibodychromatin mix was incubated in the column for 4 hr, washed eight times with modified RIPA buffer.
Chromatin was eluted with pre-warmed TE-SDS (50mM Tris pH 8.0, 10 mM EDTA, 1% SDS). ChIPenriched sample and inputs were then reverse cross-linked at 65°C overnight and treated with RNase A and proteinase K. DNA was extracted with phenol/chloroform/isoamyl alcohol, precipitated with glycogen in sodium acetate and ethanol and finally resuspended in tris-buffered water. Enrichment compared to input was analyzed by qPCR using the Viia7 thermal cycling system (Applied Biosystems). Primers are listed in Table S1 .
4C-seq
The design of VPs and preparation of 4C-seq libraries was performed as described in detail by Matelot and Noordermeer, 2016 , with only minor modifications. DpnII or its isoschiszomer MboII (New England Biolabs) were chosen as the primary restriction enzyme, and NlaIII (New England Biolabs) as the secondary restriction enzyme. ESC and EpiLC material were harvested from 150cm 2 culture flasks (TPP Techno Plastic Products AG), which provided ample material for up to four technical replicates presuming cells were healthy and near confluency. To avoid technical artifacts, crosslinking and library preparation were performed in parallel for each experiment. For each VP, approximately 1µg of library material was amplified using 16 individual PCR reactions with inverse primers containing indexed Illumina TruSeq adapters (primer sequences are listed in Table S1 ). PCR products were originally purified using the MinElute PCR purification kit (Qiagen) to remove unincorporated primer, but we found that purification was more efficiently performed using Agencourt AMPure XP beads (Beckman Coulter). Sequencing was performed on the Illumina NextSeq 500 system, using 75bp single-end reads with up to 14 VPs multiplexed per run.
RNA expression
Total RNA was extracted using Trizol (Life Technologies), then DNase-treated and column purified (Qiagen RNeasy Kit). To generate cDNA, purified RNA was reverse transcribed with SuperscriptIII (Life Technologies) primed with random hexamers. RT-qPCR was performed using the SYBR Green Master Mix on the Viia7 thermal cycling system (Applied Biosystems). Relative expression levels were normalized to the geometric mean of the Ct for housekeeping genes Rrm2 and Rplp0 with the ΔΔCt method. Primers are listed in Table S1 . Statistical analyses were performed by a two-tailed unpaired t-test using GraphPad Prism6 software.
RNA-seq libraries were prepared from 500ng of DNase-treated RNA with the TruSeq Stranded mRNA kit (Illumina). Sequencing was performed in 100pb paired-end reads using the Illumina HiSeq2500 platform.
Immunoblotting
Western blots were visualized using the ChemiDoc MP (Biorad). The antibodies are listed in the Key Resource Table. QUANTIFICATION AND STATISTICAL ANALYSIS ATAC-seq analysis 2x100bp paired-end reads were aligned onto the Mouse reference genome (mm10) using Bwa mem v0.7.5a (2) with default parameters. Duplicate reads were removed using Picard v1.130 (http://broadinstitute.github.io/picard/). Tracks were created using HOMER software v4.7 (3).
WGBS analysis
Whole-genome bisulfite sequencing data were analyzed as described in Walter et al., 2016 . Briefly, the first eight base pairs of the reads were trimmed using FASTX-Toolkit v0.0.13: http://hannonlab.cshl.edu/fastx_toolkit/index.html Adapter sequences were removed with Cutadapt v1.3 (4) and reads shorter than 16 bp were discarded. Cleaned sequences were aligned onto the mouse reference genome (mm10) using Bismark v0.12.5 (5) with The Liz promoter is DNA methylated and silent on the maternal allele. Conversely, the paternal allele is expressed, leading to de novo DNA methylation at the paternal sDMR, and Zdbf2 activation. The epigenetic setting is programmed around the time of implantation in embryogenesis, but is then stably maintained throughout life. (B) H3K27ac ChIP-qPCR at control loci. E Jarid2 is active in ESCs and EpiLCs, whereas E Fgf5 is a poised enhancer . pPax5 is a negative control. Data is shown as ± s.e.m. from three biological replicates. (C) In vivo and in cellula chromatin landscape of Liz/Zdbf2 locus. Top panel: in the in vivo ICM, the chromatin accessibility and H3K27me3 patterns resemble the in cellula system. Bottom panels: published data showing that active and poised enhancers are bound by P300 and OCT4. E1-3 are marked by H3K4me1, but not E4. E4 exhibits higher vertebrate conservation (PhastCons) than other enhancer elements.
Statistical analyses were performed by two-tailed unpaired t-test: * P ≤ 0.05, ** P ≤ 0.01 Statistical analyses were performed by two-tailed unpaired t-test: * P ≤ 0.05, ** P ≤ 0.01 αEED αLAMIN1B αH3K27me3 αH3 WT ∆CTCF_PS E4 E4 pZdbf2 pZdbf2
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